Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Total Liabilities (2012 - 2026)

Kamada's (KMDA) quarterly Total Liabilities came in at $113.6 million in Q2 2026, up 4.98% on a YoY basis from $108.2 million in Q2 2025, and down 8.11% quarter-over-quarter from $123.6 million in Q1 2026.

Analysis

Kamada (KMDA) Total Liabilities (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Total Liabilities for 15 consecutive years, with $113.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Liabilities rose 4.98% year-over-year to $113.6 million; the trailing twelve-month figure through Jun 2026 stood at $113.6 million (up 4.98% YoY), and the FY2025 full-year result was $37.2 million, up 813.49% from the prior year.
  • Total Liabilities retreated to $113.6 million in Q2 2026 per KMDA's latest filing, from $123.6 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $304.0 million in Q2 2022 and bottomed at $4.1 million in Q4 2024.
  • Historically, Total Liabilities has averaged $112.1 million across 5 years, with a median of $112.8 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 61385.83% in 2022, then plunged 96.98% in 2023.
  • Over 5 years, Total Liabilities stood at $146.4 million in 2022, then slumped by 96.98% to $4.4 million in 2023, then retreated by 7.92% to $4.1 million in 2024, then surged by 813.49% to $37.2 million in 2025, then soared by 205.63% to $113.6 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $113.6 million, $123.6 million, and $37.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 211.30 Bn 197.31 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 180.97 Bn 177.79 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 132.27 Bn 124.42 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 82.93 Bn 74.93 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 61.53 Bn 56.35 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.27 Bn 49.13 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 34.46 Bn 31.15 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.16 Bn 29.88 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 30.08 Bn 30.08 Bn 1.16 Mn 384.62 Mn
10 Kamada 473.85 Mn 403.72 Mn 22.47 Mn 113.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 113.60 Mn
Mar 31, 2026 123.63 Mn
Dec 31, 2025 37.17 Mn
Sep 30, 2025 111.98 Mn
Jun 30, 2025 108.22 Mn
Mar 31, 2025 123.15 Mn
Dec 31, 2024 4.07 Mn
Sep 30, 2024 95.94 Mn
Jun 30, 2024 99.89 Mn
Mar 31, 2024 92.02 Mn
Dec 31, 2023 4.42 Mn
Sep 30, 2023 98.67 Mn
Jun 30, 2023 137.64 Mn
Mar 31, 2023 141.99 Mn
Dec 31, 2022 146.36 Mn
Sep 30, 2022 147.09 Mn
Jun 30, 2022 303.96 Mn
Mar 31, 2022 127.95 Mn
Dec 31, 2021 141.84 Mn
Sep 30, 2021 -240,000.00